ArticleWorld journal of microbiology & biotechnology2025
Immunomodulatory effect of Qihuang Biwen decoction and its postbiotic product.
Article in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Research advances on postbiotics in promoting skin wound healing: mechanisms, formulations, and clinical translation.Frontiers in immunology · 2026Review
- Focus on gut microbiota regulation: exploring the potential of fermented traditional Chinese medicines in the prevention and treatment of type 2 diabetes mellitus.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Microbial fermentation is a promising strategy to enhance the efficacy and functional properties of herbs. A traditional Chinese medicine formula, known as the Qihuang Biwen decoction (QHBW), has been shown to have immunomodulatory benefits in clinical and experimental studies. Nevertheless, few studies have investigated the effects of microbial-fermented QHBW (FQHBW) on immunity. In this study, we used one-way and Plackett-Burman analyses to establish the preparation process of FQHBW (crucial parameters: ratio of bacterial strains LZU-J-TSL6 and LZU-S-ZCJ was 3:1, inoculum quantity was 3%, temperature was 37℃, time was 37 h). The study found that FQHBW has increased total polysaccharide, total acid, and antioxidant capacities. The increased constituents after fermentation potentially contribute to improving the ability of FQHBW to regulate immunity. Next, its immunostimulatory activity was evaluated in cyclophosphamide (CTX)-treated mice, and the possible mechanism was studied by microbiome-metabolome analysis. As expected, FQHBW effectively ameliorated CTX-induced immunosuppression by improving organ index, lymphocyte proliferation, phagocytic function, cytokine secretion, and antioxidant profile. It protected against CTX-induced intestinal dysbiosis by promoting the abundance of Oscillospira, Allobaculum, and Coprococcus, while moderately increasing Akkermansia and reducing Staphylococcus and Streptococcus. FQHBW primarily influenced amino acid and nucleotide metabolism to benefit immunity. Unlike QHBW, FQHBW uniquely up-regulates dopamine synapses, tryptophan metabolism, and nicotinate and nicotinamide metabolism, promoting host anti-oxidation, immune system remodeling, and disease resistance. This study suggests that microbial fermentation is indeed an effective strategy to alter the properties and function of QHBW. FQHBW has the potential to replace QHBW as a novel immunoenhancer and intestinal microecological regulator.
Indexed as
Identifiers
40999268What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.